BRK-B vs FDS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
FDS presents a stable but mediocre financial profile with a Piotroski F-Score of 4/9, indicating a lack of strong fundamental momentum. The stock is severely overvalued relative to its deterministic baselines, trading at $224.12 against a Graham Number of $142.49 and an Intrinsic Value of $108.71. While the company maintains high profitability (ROE 28.08%), it is currently plagued by negative earnings growth and a maximum bearish technical trend (0/100). The long-term price trajectory is deeply concerning, with a 1-year decline of 46.9%.
Compare Another Pair
Related Comparisons
BRK-B vs FDS: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and FactSet Research Systems Inc. (FDS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.